The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2022 | Developing skin punch biopsies as a potential diagnostic tool for neuropathy in WM
Jorge Castillo, MD, Dana-Farber Cancer Institute, Boston, MA, discusses ongoing research into the development of skin punch biopsy as a potential future diagnostic tool for neuropathy in Waldenström’s macroglobulinemia (WM) patients. Working with various stains, immunofluorescence and electron microscopy, researchers are looking to establish an association between IgM deposition and neuropathy, and create a tool that can diagnose the commonly occurring condition. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
AstraZeneca: Research Funding; Roche: Consultancy; TG Therapeutics: Research Funding; Pharmacyclics: Consultancy, Research Funding; Cellectar: Consultancy; Beigene: Consultancy, Research Funding; Janssen: Consultancy; Abbvie: Consultancy, Research Funding.
